✨
AI Summary
- Recursion CEO Chris Gibson accelerates biopharma with AI.
- AI and machine learning are supercharging drug discovery and development.
- The company aims to increase efficiency in the biopharmaceutical industry.
Guests on This Episode
CG
Chris Gibson
1 podcast appearance